Brief: BRAIN Biotech - BRAIN-Engineered-Cas (BEC) Considered Patentable Technology
Jan 12 (Reuters) - BRAIN BIOTECH AG BNNn.DE :
* SAID ON TUESDAY: BRAIN-ENGINEERED-CAS (BEC) CONSIDERED
PATENTABLE TECHNOLOGY
* PATENT APPLICATION AND SEARCH REPORT ARE EXPECTED TO BE
PUBLISHED BY THE WIPO SHORTLY AFTER JANUARY 21ST, 2022
Source text for Eikon: urn:newsml:reuters.com:*:nEQchn64la
Further company coverage: BNNn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on BRAIN Biotech AG
See all newsBrief: BRAIN Biotech 9M EBITDA EUR -1.6 Million
CEOs Lukas Linnig And Michael Krohn To Leave Co
Brief: Brain Biotech Signs Exclusive Pharma Licensing Agreement With Akribion For Up To EUR 92.3 Million Milestone Fees Plus Royalties
Brief: BRAIN Biotech 9M Adj. EBITDA at EUR -1.2 Million
Europe Research Roundup: AB Foods, Bunzl, Barratt